The action of vasopressors on isolated uterine arteries.
D000328:Adult; D000818:Animals; D001158:Arteries / Q000187:drug effects*; D002245:Carbon Dioxide / Q000494:pharmacology; D004298:Dopamine / Q000008:administration & dosage / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004809:Ephedrine / Q000008:administration & dosage / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D006221:Halothane / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008012:Lidocaine / Q000494:pharmacology; D008616:Mephentermine / Q000008:administration & dosage / Q000494:pharmacology; D008680:Metaraminol / Q000494:pharmacology; D008875:Middle Aged; D009584:Nitrogen / Q000494:pharmacology; D009609:Nitrous Oxide / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010100:Oxygen / Q000494:pharmacology; D010656:Phenylephrine / Q000494:pharmacology; D011247:Pregnancy; D012756:Sheep; D014599:Uterus / Q000098:blood supply*; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014666:Vasomotor System / Q000187:drug effects*
D014662:Vasoconstrictor Agents; D002245:Carbon Dioxide; D010656:Phenylephrine; D008680:Metaraminol; D008012:Lidocaine; D004809:Ephedrine; D009609:Nitrous Oxide; D009584:Nitrogen; D010100:Oxygen; D008616:Mephentermine; D006221:Halothane; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine